The global Advanced Cancer Pain Management Market Size is estimated to be worth US$ 7265.44 million in 2023 and US$ 11,540 million by 2033, growing at a CAGR of 4.74% over the forecast period. Rapid technological advancements in neuromodulation techniques for treating neuropathic cancer pain, rising investment to propel cancer research, the rapidly increasing burden …